Quantitative analysis for CryoPort Inc. Common Stock (CYRX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (55.0) (grade C). 23 signals analyzed (18 differentiated alt-data).
CYRX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-09 | $9.83 | $9.09 | $9.76 |
| 2026-04-21 | $10.88 | $10.59 | $10.68 |
| 2026-05-01 | $10.50 | $10.11 | $10.35 |
| 2026-05-13 | $13.48 | $13.06 | $13.25 |
| 2026-05-26 | $14.29 | $13.90 | $13.96 |
| 2026-06-05 | $16.10 | $15.52 | $15.70 |
| 2026-06-17 | $15.22 | $14.51 | $14.57 |
| 2026-06-30 | $16.13 | $15.30 | $15.70 |
| 2026-07-13 | $16.27 | $15.56 | $15.71 |
| 2026-07-23 | $16.71 | $15.88 | $16.03 |
| 2026-08-04 | $15.60 | $15.09 | $15.22 |
| 2026-08-14 | $15.35 | $14.80 | $15.25 |
How CryoPort Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
CryoPort Inc. Common Stock (CYRX) scores Hold (55.0), with no measured dimension below 47. Its highest are analyst consensus at 86, technicals at 84, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 86 |
| technicals | 84 |
| competitive moat | 55 |
| earnings quality | 52 |
| valuation | 47 |
StoQuant analyzes 23 signals (18 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on CryoPort Inc. Common Stock (CYRX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/CYRX"><img src="https://stoquant.com/badge/CYRX.svg" alt="CryoPort Inc. Common Stock (CYRX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Daily Q-Score changes, insider buy clusters, and ML forecast updates for the tickers you follow. Email only, no account needed. See a sample digest.